• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

N-Desmethyl Dovitinib-[d8]

General Information
Catalog: BLP-013060
CAS: 1246814-93-6
Molecular Formula: C20H11D8FN6O
Molecular Weight: 386.45
Chemical Structure
N-Desmethyl Dovitinib-[d8]
Description N-Desmethyl Dovitinib-[d8] is the labelled analogue of N-Desmethyl Dovitinib, which is a derivative of Dovitinib. Dovitinib is a receptor tyrosine kinase (RTK) inhibitor that exhibits a suppressive effect on tumor growth.
Synonyms N-Desmethyl Dovitinib D8; 4-Amino-5-fluoro-3-[6-(1-piperazinyl-d8)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
IUPAC Name 4-amino-5-fluoro-3-[6-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one
Related CAS 668432-44-8 (unlabelled)
Canonical SMILES C1CN(CCN1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N
InChI InChI=1S/C20H19FN6O/c21-12-2-1-3-14-16(12)18(22)17(20(28)26-14)19-24-13-5-4-11(10-15(13)25-19)27-8-6-23-7-9-27/h1-5,10,23H,6-9H2,(H,24,25)(H3,22,26,28)/i6D2,7D2,8D2,9D2
InChI Key DRUNJGIEUWMQHG-COMRDEPKSA-N
Purity >95%

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x